Ventricular arrhythmias (VAs) originating from the left ventricular outflow tract (LVOT) are frequently managed with endocardial radiofrequency (RF) catheter ablation. However, a challenging subset arises from the left ventricular summit (LV summit)—the highest region of the left ventricular epicardium, bounded by the coronary vasculature [1].
The epicardial nature of these foci often limits the efficacy of conventional endocardial RF energy. At the same time, direct percutaneous epicardial mapping and ablation are technically demanding and carry a high risk of coronary artery injury.
Recently, dual-energy ablation platforms combining traditional thermal RF with non-thermal, tissue-selective Pulsed Field Ablation (PFA) have emerged as a novel therapeutic option. This technology allows operators to leverage both energy modalities using a single catheter.
We report a case of a patient with a 10-year history of drug-refractory premature ventricular contractions (PVCs) originating from the LV summit, which was successfully eliminated via an endocardial approach using a novel flexible-tip dual-energy (RF/PFA) catheter ablation system.
Case Presentation
Clinical Presentation and Baseline Assessment
A 72-year-old male with an unremarkable cardiovascular history presented with a 10-year history of frequent, highly symptomatic premature ventricular contractions (PVCs). The arrhythmias were persistently refractory to multiple antiarrhythmic drug therapies. The patient was admitted to our cardiac rhythm center for an electrophysiological study (EPS) and catheter ablation.
At baseline, the resting 12-lead electrocardiogram (ECG) demonstrated sinus rhythm interspersed with frequent PVCs. The PVC morphology exhibited a right bundle branch block (RBBB) pattern and an inferior axis (+100 degrees).
Electrophysiological Study and Mapping
The procedure was performed under local anesthesia and ultrasound-guided vascular access. Two 6-Fr sheaths were placed in the right femoral vein, and one 8-Fr sheath was placed in the right femoral artery.
Diagnostic mapping and ablation equipment included:
- A 10-polar steerable catheter positioned in the coronary sinus.
- A multipolar high-density mapping catheter (HD-Grid Advisor, Abbott).
- A steerable intracardiac echocardiography (ICE) catheter (ViewFlex™ Xtra, Abbott).
- A 3.5mm tip, flexible, irrigated-tip, steerable dual-energy ablation catheter (TactiFlex™ Duo Ablation Catheter, Sensor Enabled, Abbott).
Three-dimensional electroanatomical mapping was executed utilizing the EnSite X™ system (Abbott), while conventional electrophysiological recordings were monitored via the LABSYSTEM PRO™ system (Boston Scientific).
Retrograde aortic access via the right femoral artery allowed detailed electroanatomical mapping of both the aortic root and the left ventricular outflow tract (LVOT). During mapping of the frequent PVCs, the site of maximum electrical prematurity was identified within the left ventricle, precisely below the left coronary cusp (LCC) of the aortic valve, demonstrating an activation time of −25 ms relative to the onset of the surface QRS complex (Fig. 2, EP recording 1).
Intervention and Ablation Strategy
Initially, conventional endocardial RF ablation was delivered at the target site with power titrated up to 40 Watts. This application yielded only transient suppression of the PVCs. Upon recurrence, the PVCs exhibited a slightly modified, more vertical QRS axis (EP Recording 2).
Further analysis of the QRS morphology revealed a maximum deflection index (MDI) greater than 0.55. This high MDI value raised a strong clinical suspicion of an epicardial source residing within the LV summit region.
To overcome the depth limitation of thermal RF energy without attempting a hazardous epicardial approach, the decision was made to utilize pulsed field energy. Prior to PFA administration to prevent coronary artery spasm, the patient received an intravenous nitroglycerin bolus. Successive, overlapping PFA lesions were delivered endocardially at the site of interest using the dual-energy catheter. The initial PFA delivery successfully induced a transient accelerated idioventricular rhythm arising from the focus, exhibiting the identical morphology to the patient’s clinical PVC (EP Recording 3). Continued PFA application resulted in the complete and definitive suppression of the ectopic activity.
Following a standard 30-minute waiting period, the complete absence of any spontaneous or induced PVCs was verified. The venous sheaths were removed, and venous hemostasis was achieved via manual compression until complete closure was secured. The 8-Fr arterial sheath was similarly removed, and arterial hemostasis was successfully achieved using manual compression followed by the application of a tight pressure dressing.
The procedural course was entirely uneventful, without any acute vascular or cardiac complications. The patient experienced a smooth post-operative recovery, achieving full mobilization the following day, and was discharged in stable condition.
Discussion
This case highlights the therapeutic complexity of managing VAs originating from the LV summit and exemplifies the clinical utility of endocardial dual-energy ablation platforms. The LV summit is notoriously difficult to ablate. Traditional endocardial RF applications often fail due to the thick myocardium or epicardial fat buffering the thermal energy, as seen initially in our patient where 40W RF energy achieved only transient suppression. While direct epicardial ablation via a percutaneous subxiphoid approach is an option, it is limited in the LV summit region due to the close proximity of the epicardial coronary arteries, risking catastrophic coronary stenosis or occlusion.
In clinical practice, specific electrocardiographic parameters—most notably a Maximum Deflection Index (MDI) >0.55 or a pseudodelta wave ≥34 ms—serve as powerful indicators of an epicardial arrhythmia origin. Identifying these features allows the clinician to suspect an LV summit substrate early in the diagnostic workup [2].
The transition to PFA in this scenario offered a crucial mechanistic advantage. PFA utilizes high-voltage, ultra-short electrical pulses to create irreversible electroporation in cell membranes. Importantly, delivering consecutive, overlapping PFA pulses at the same target site—a strategy known as lesion stacking—drives the ablation energy deeper into the tissue. Seemingly due to increased permeability across the cell membrane made by sequential application delivery, application repetition leads independently to deeper and more transmural lesion formation [3]. This biophysical accumulation allows the energy to reach deep-seated or epicardial arrhythmogenic foci without causing thermal collateral damage. Furthermore, because myocardial tissue has a lower threshold for electroporation than adjacent structures like coronary arteries, large nerves, or fibrous valvular tissue, PFA provides an enhanced safety profile when working near the aortic root and coronary cusps.
Crucially, the utilization of a dual-energy platform with a flexible-tip catheter allowed the operator to seamlessly transition from RF to PFA without changing hardware, minimizing procedural time and maintaining stable contact at the exact site of electrical prematurity below the LCC. The induction of an accelerated idioventricular rhythm during the initial PFA pulses, which exhibited the identical morphology to the clinical PVC, served as an immediate confirmation of precise tissue engagement at the arrhythmogenic source, followed by definitive isolation.
References
- Das SK, Hawson J, Koh Y, Lim MW, D’Ambrosio P, Virk SA, Liang D, Watts T, Padilla JR, Nanthakumar K, Kumar S, Wong M, Sparks PB, Al-Kaisey A, Pathik B, McLellan A, Morton JB, Kistler PM, Kalman JM, Lee G, Anderson RD. Left Ventricular Summit Arrhythmias: State-of-the-Art Review of Anatomy, Mapping, and Ablation Strategies. JACC Clin Electrophysiol. 2024 Nov;10(11):2516-2539. doi: 10.1016/j.jacep.2024.09.008. Epub 2024 Oct 30. PMID: 39480387.
- Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite LR, Al-Khatib SM, Anter E, Berruezo A, Callans DJ, Chung MK, Cuculich P, d’Avila A, Deal BJ, Della Bella P, Deneke T, Dickfeld TM, Hadid C, Haqqani HM, Kay GN, Latchamsetty R, Marchlinski F, Miller JM, Nogami A, Patel AR, Pathak RK, Saenz Morales LC, Santangeli P, Sapp JL Jr, Sarkozy A, Soejima K, Stevenson WG, Tedrow UB, Tzou WS, Varma N, Zeppenfeld K. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary. Heart Rhythm. 2020 Jan;17(1):e155-e205. doi: 10.1016/j.hrthm.2019.03.014. Epub 2019 May 10. PMID: 31102616; PMCID: PMC8459311.
- Di Biase L, Marazzato J, Gomez T, Byun E, Zou F, Grupposo V, Mohanty S, La Fazia VM, Ammirati G, Lin A, Garcia DY, Della Rocca D, Al Ahamad A, Schiavone M, Gasperetti A, Freilich M, Serna JC, Forleo G, Liu X, Lakkireddy D, Tondo C, Natale A, Zhang XD. Application repetition and electrode-tissue contact result in deeper lesions using a pulsed-field ablation circular variable loop catheter. Europace. 2024 Aug 30;26(9):euae220. doi: 10.1093/europace/euae220. PMID: 39150065; PMCID: PMC11393494.


References
- Das SK, Hawson J, Koh Y, Lim MW, D’Ambrosio P, Virk SA, Liang D, Watts T, Padilla JR, Nanthakumar K, Kumar S, Wong M, Sparks PB, Al-Kaisey A, Pathik B, McLellan A, Morton JB, Kistler PM, Kalman JM, Lee G, Anderson RD. Left Ventricular Summit Arrhythmias: State-of-the-Art Review of Anatomy, Mapping, and Ablation Strategies. JACC Clin Electrophysiol. 2024 Nov;10(11):2516-2539. doi: 10.1016/j.jacep.2024.09.008. Epub 2024 Oct 30. PMID: 39480387.
- Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N, Aguinaga L, Leite LR, Al-Khatib SM, Anter E, Berruezo A, Callans DJ, Chung MK, Cuculich P, d’Avila A, Deal BJ, Della Bella P, Deneke T, Dickfeld TM, Hadid C, Haqqani HM, Kay GN, Latchamsetty R, Marchlinski F, Miller JM, Nogami A, Patel AR, Pathak RK, Saenz Morales LC, Santangeli P, Sapp JL Jr, Sarkozy A, Soejima K, Stevenson WG, Tedrow UB, Tzou WS, Varma N, Zeppenfeld K. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary. Heart Rhythm. 2020 Jan;17(1):e155-e205. doi: 10.1016/j.hrthm.2019.03.014. Epub 2019 May 10. PMID: 31102616; PMCID: PMC8459311.
- Di Biase L, Marazzato J, Gomez T, Byun E, Zou F, Grupposo V, Mohanty S, La Fazia VM, Ammirati G, Lin A, Garcia DY, Della Rocca D, Al Ahamad A, Schiavone M, Gasperetti A, Freilich M, Serna JC, Forleo G, Liu X, Lakkireddy D, Tondo C, Natale A, Zhang XD. Application repetition and electrode-tissue contact result in deeper lesions using a pulsed-field ablation circular variable loop catheter. Europace. 2024 Aug 30;26(9):euae220. doi: 10.1093/europace/euae220. PMID: 39150065; PMCID: PMC11393494.